Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India
Ingredion (NYSE: INGR) said it will form a joint venture with Sanstar Limited and make a 9% equity investment in Sanstar, according to a company statement. The partners plan a greenfield project to manufacture specialty pharmaceutical and other ingredients in India. Ingredion cited growth in India’s pharma and specialty ingredients markets and said the venture aims to expand its local platform and export opportunities.